| Market Cap | ₹5,384Cr |
| ROE | 16.86% |
| P/E Ratio(TTM) | 29.52 |
| EPS(TTM) | 22.66 |
| P/B Ratio | 4.98 |
| Dividend Yield | 0.15% |
| Industry P/E | 39.41 |
| Book Value | 134.41 |
| Debt to Equity | 0.00 |
| Face Value | 2 |
| Managing Director | Mr. Satish Wagh |
| Founded | 2008 |
| NSE Symbol | SUPRIYA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.41 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.12 | ||
| Wockhardt | NA (0.00%) | -445.35 | ||
| Natco Pharma | NA (0.00%) | 9.60 |